跳至主要内容
临床试验/ISRCTN71371114
ISRCTN71371114已完成不适用

Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischaemic stroke: a prospective randomised placebo controlled trial

ational Science Council (Taiwan)0 个研究点目标入组 220 人开始时间: 2011年1月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients aged greater than 45 years, either sex

排除标准

  • Patients with history of the followings were excluded from the study:
  • 1. Intracranial haemorrhage
  • 2. Surgery or trauma within the preceding 3 months
  • 3. Abnormal liver function
  • 4. Haematology disorders
  • 5. Renal insufficiency (serum creatinine greater than 1.5 mg/dL)
  • 6. Malignancy
  • 7. Febrile disorders
  • 8. Acute or chronic inflammatory disease at study entry
  • 9. Liver cirrhosis
  • 10. Atrial fibrillation
  • 11. Congestive heart failure
  • 12. Contraindications for magnetic resonance imaging (MRI) examination
  • 13. No evidence of acute IS by MRI study
  • 14. Myeloproliferative disorder
  • 15. Antibodies or being allergic to EPO
  • 16. Pregnancy
  • 17. Haemoglobin level greater than 15.0 g/d

研究者

发起方
ational Science Council (Taiwan)

相似试验